Bio-Path Holdings
OTC: BPTHBellaire, US · Wyoming corporation
Biotech
Founders & leadership
DP
Douglas P, MorrisDirector
PH
Peter H. NielsenExecutive Officer, Director
MP
Mark P. ColonneseDirector
PD
Paul D. AubertDirector
HW
Heath W. CleaverDirector
AS
Aline SherwoodDirector
Reported raises · per SEC filings
Form D private placements▶$4MraisedOct 2024 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedOct 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul D. AubertDirector
- Peter H. NielsenExecutive Officer, Director
- Douglas P, MorrisDirector
- Heath W. CleaverDirector
- Aline SherwoodDirector
- Offering amount
- $4M
- Amount sold
- $4M
- Sales commissions
- $340K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJun 2024 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedJun 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aline SherwoodDirector
- Peter H. NielsenExecutive Officer, Director
- Paul D. AubertDirector
- Douglas P. MorrisDirector
- Heath W. CleaverDirector
- Offering amount
- $4M
- Amount sold
- $4M
- Sales commissions
- $340K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedApr 2024 · 3 investors · BiotechnologyRule 506(b)
▶$1.3MraisedApr 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter H. NielsenExecutive Officer, Director
- Heath W. CleaverDirector
- Paul D. AubertDirector
- Douglas P. MorrisDirector
- Aline SherwoodDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Sales commissions
- $102.8K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$317.9KraisedApr 2024 · 1 investors · BiotechnologyRule 506(b)
▶$317.9KraisedApr 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter H. NielsenExecutive Officer, Director
- Heath W. CleaverDirector
- Aline SherwoodDirector
- Douglas P. MorrisDirector
- Paul D. AubertDirector
- Offering amount
- $317.9K
- Amount sold
- $317.9K
- Sales commissions
- $25.5K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedNov 2022 · 5 investors · BiotechnologyRule 506(b)
▶$2.3MraisedNov 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter H. NielsenExecutive Officer, Director
- Heath W. CleaverDirector
- Paul D. AubertDirector
- Douglas P. MorrisDirector
- Aline SherwoodDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- Sales commissions
- $140K
- Placement agents
- ROTH Capital Partners, LLC
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedMar 2019 · 4 investors · BiotechnologyRule 506(b)
▶$1.4MraisedMar 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark P. ColonneseDirector
- Douglas P. MorrisDirector
- Heath W. CleaverDirector
- Peter H. NielsenExecutive Officer, Director
- Paul D. AubertDirector
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- Sales commissions
- $1.3M
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$83.8KraisedJan 2019 · 1 investors · BiotechnologyRule 506(b)
▶$83.8KraisedJan 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas P. MorrisDirector
- Heath W. CleaverDirector
- Paul D. AubertDirector
- Mark P. ColonneseDirector
- Peter H. NielsenExecutive Officer, Director
- Offering amount
- $83.8K
- Amount sold
- $83.8K
- Sales commissions
- $42.5K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$987.7KraisedJan 2019 · 8 investors · BiotechnologyRule 506(b)
▶$987.7KraisedJan 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas P. MorrisDirector
- Mark P. ColonneseDirector
- Paul D. AubertDirector
- Peter H. NielsenExecutive Officer, Director
- Heath W. CleaverDirector
- Offering amount
- $987.7K
- Amount sold
- $987.7K
- Sales commissions
- $137.4K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.